Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity

Analytical Biochemistry
S P MonkarshY C Pan

Abstract

The success of recombinant interferon alpha in the clinic in part is limited by two properties of the protein: short serum half-life and immunogenicity. To improve these properties, interferon alpha-2a was conjugated with polyethylene glycol (PEG-5000). A homogeneous preparation of monopegylated interferon alpha-2a was subjected to vigorous analytical and activity characterization. A newly developed ampholyte-free chromatofocussing-like cation-exchange HPLC method utilizing a sulfopropyl resin was used to separate the monopegylated protein into 11 species. Peptide mapping, sequencing, and mass spectrometric analyses indicated that these species are positional isomers where each isomer represents a single polymer molecule conjugated to one specific lysine residue. No species with a modification at the amino terminus was observed. All 11 isomers show antiviral and antiproliferative activities in the same range as the parent monopegylated interferon alpha-2a.

References

Aug 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·R L CavalieriS Pestka
May 23, 1979·Biochimica Et Biophysica Acta·A Abuchowski, F F Davis
Aug 1, 1992·Journal of Interferon Research·E N Fish
Oct 1, 1989·Urology·R J Spiegel
Mar 5, 1987·The New England Journal of Medicine·M S HershfieldA L Kobayashi
Feb 1, 1981·Journal of Virology·S RubinsteinS Pestka
Feb 12, 1993·Journal of Chromatography·S P MonkarshS K Roy

❮ Previous
Next ❯

Citations

Jan 19, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·M GraceR Bordens
May 17, 2011·Chemistry Central Journal·Yasuo YoshiokaYasuo Tsutsumi
Aug 7, 2004·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yasuo Yoshioka
Mar 6, 2013·Bioconjugate Chemistry·Hailong ZhangXue-Long Sun
Feb 25, 2009·Expert Opinion on Drug Delivery·Pascal Bailon, Chee-Youb Won
Dec 18, 2002·Journal of Pharmaceutical Sciences·Haeshin Lee, Tae Gwan Park
Jan 15, 2008·Biochimica Et Biophysica Acta·Hiroyuki YamaguchiMotoo Yamasaki
Jan 25, 2002·Clinics in Podiatric Medicine and Surgery·David N Quinn, Sheryl A Pfeil
Apr 1, 2004·Expert Opinion on Therapeutic Patents·Nicolò Pipitone, Costantino Pitzalis
May 31, 2006·Expert Opinion on Pharmacotherapy·Mitsuhiko Moriyama, Yasuyuki Arakawa
Feb 18, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·David Pfister, Massimo Morbidelli
Nov 20, 2003·Trends in Biotechnology·Samantha Lien, Henry B Lowman
Aug 4, 1999·Antiviral Chemistry & Chemotherapy·R F SchinaziS Dagan
Feb 15, 2001·Current Gastroenterology Reports·M L Shiffman
Jun 15, 2007·Biochimica Et Biophysica Acta·Hiroko ShibataYasuo Tsutsumi
Feb 1, 2010·Viruses·Piyanuch Wonganan, Maria A Croyle
Jul 17, 2018·Journal of Drug Targeting·Daniel Cristian Ferreira SoaresMarli Luiza Tebaldi
Aug 4, 2005·Pharmaceutical Research·Jose RamonEugenio Hardy
Apr 1, 2003·Nature Biotechnology·Yoko YamamotoTadanori Mayumi
Nov 15, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·J F Eliason
Dec 18, 2013·Biological & Pharmaceutical Bulletin·Fan ZhangHai-tong Wan
Dec 11, 2013·Macromolecular Rapid Communications·Dorothee E BorchmannMarcus Weck
Sep 10, 2008·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Francesco M Veronese, Anna Mero
Aug 14, 2013·Biotechnology and Bioengineering·Benjamin MaiserJürgen Hubbuch
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroko ShibataYasuo Tsutsumi
Dec 22, 1999·Biochimica Et Biophysica Acta·T L TalaricoC J Stacey
Apr 25, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Seung Ho ChoiTae Gwan Park
Sep 15, 2000·Infectious Disease Clinics of North America·C P CheneyC Graham
Jan 20, 2009·Biochimica Et Biophysica Acta·Margherita Gonnelli, Giovanni B Strambini
May 14, 2011·Journal of Controlled Release : Official Journal of the Controlled Release Society·Anna MeroGianfranco Pasut

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.